Abstract
Low-dose total body irradiation (LD-TBI) has been shown to be an effective therapy for patients with hematologic malignancies. The application of this method has fallen out of favor as newer systemic therapies have been developed. Nevertheless, for management of many of these hematologic malignancies, no prospective randomized trial has shown that any other treatment is unequivocally superior to LD-TBI. The precise mechanism of action is uncertain but it is believed by some to be at least partly immunologically mediated. In this review, we shall discuss the clinical data on this method along with some new potential applications. We also discuss some of the potential immunological mechanisms behind LD-TBI and consider future possibilities.
Similar content being viewed by others
References
Safwat A (2000) The immunobiology of low-dose total-body irradiation: more questions than answers. Radiat Res 153:599–604
Johnson RE (1966) Evaluation of fractionated total-body irradiation in patients with leukemia and disseminated lymphomas. Radiology 86:1085–1089
Qasim MM (1979) Total body irradiation as a primary therapy in non-Hodgkin lymphoma. Clin Radiol 30:287–286
Chaffey JT, Rosenthal DS, Pinkus F, Hellman S (1975) Advanced lymphosarcoma treated by total body irradiation. Br J Cancer 31(SUPPL 2):441–449
Hoppe RT, Kushlan P, Kaplan HS, Rosenberg SA, Brown BW (1981) The treatment of advanced stage favorable histology non-Hodgkin’s lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation. Blood 58:592–598
Wang B, Li B, Dai Z et al (2014) Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells. Int J Biochem Cell Biol 55:98–108
Dreyling M, Ghielmini M, Marcus R et al (2011) Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 22:vi59–vi63
Lowry L, Smith P, Qian W et al (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 100:86–92
Kamstrup MR, Gniadecki R, Iversen L et al (2015) Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis. Int J Radiat Oncol Biol Phys 92(1):138–143
Hoppe RT, Harrison C, Tavallaee M et al (2015) Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials. J Am Acad Dermatol 72(2):286–292
Haas RL (2009) Low dose radiotherapy in indolent lymphomas, enough is enough. Hematol Oncol 27(2):71–81
Ganem G, Cartron G, Girinsky T, Haas RL, Cosset JM, Solal-Celigny P (2010) Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks. Int J Radiat Oncol Biol Phys 78(4):975–982
Ganem G, Lambin P, Socié G et al (1994) Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin’s lymphomas. Hematol Oncol 12(1):1–8
Girinsky T, Paumier A, Ferme C et al (2012) Low-dose radiation treatment in pulmonary mucosa-associated lymphoid tissue lymphoma: a plausible approach? A single-institution experience in 10 patients. Int J Radiat Oncol Biol Phys 83(3):e385–e389
Choi NC, Timothy AR, Kaufman SD, Carey RW, Aisenberg AC (1979) Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin’s lymphoma. Cancer 43:1636–1642
Safwat A, Bayoumy Y, El-Sharkawy N, Shaaban K, Mansour O, Kamel A (2003) The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemoresistant non-Hodgkin’s lymphoma. Radiother Oncol 69:33–36
Cuttler JM, Pollycove M (2003) Can cancer be treated with low doses of radiation? J Am Phys Surg 8:108–111
Oakley PA (2015) Is use of radiation Hormesis the missing link to a better cancer treatment? Journal of Cancer Therapy 6:601–605
Song KH, Kim MH, Kang SM et al (2015) Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation. Int J Radiat Biol 23:1–9 [Epub ahead of print]
Bayoumi Y, Radwan A (2015) Low dose total body irradiation for relapsed low grade non-Hodgkin’s lymphoma: experience of National Cancer Institute, Cairo. Journal of Cancer Therapy 6:25–33
Cao M, Cabrera R, Xu Y, Liu C, Nelson D (2011) Different radiosensitivity of CD4+CD25+ regulatory T cells and effector T cells to low dose gamma irradiation in vitro. Int J Radiat Biol 87(1):71–80
Welsh JS (2004) Waldenstrom’s Macroglobulinemia treated with fractionated low-dose total body irradiation. Case Rep Clin Pract Rev 5:CS425–CS431
Chaffey JT, Rosenthal DS, Moloney WC, Hellman S (1976) Total body irradiation as treatment for lymphosarcoma. Int J Radiat Oncol Biol Phys 1(5–6):399–405
Brereton HD, Young RC, Longo DL et al (1979) A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin’s lymphoma. Cancer 43:2227–2231
Anonymous (1981) British National Lymphoma Investigation Report: a prospective comparison of combination chemotherapy with total body irradiation in the treatment of advanced non-Hodgkin’s lymphoma. Clin Oncol 7:193–200
Meerwaldt JH, Carde P, Burgers JM et al (1991) Low dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern. Int J Radiat Oncol Biol Phys 21:1167–1172
Weick JK, Antunez A, Kraus TA (1983) The combined modality therapy of diffuse histology non-Hodgkin’s lymphoma with CHOP and total body irradiation. Int J Radiat Oncol Biol Phys 9:1205–1207
Richaud PM, Soubeyran P, Eghbali H et al (1998) Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin’s lymphoma: results of a pilot study. Int J Radiat Oncol Biol Phys 40(2):387–390
Johnson RE, Canellos GP, Young RC, Chabner BA, DeVita VT (1978) Chemotherapy (cyclophosphamide, vincristine, and prednisone) versus radiotherapy (total body irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep 62:321–325
Travis LB, Weeks J, Curtis RE et al (1996) Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin’s lymphoma. J Clin Oncol 14:565–571
Ellis M, Lishner M (1993) Second malignancies following treatment in non-Hodgkin’s lymphoma. Leuk Lymphoma 9:337–342
Kollmannsberger C, Hartmann JT, Kanz L, Bokemeyer C (1998) Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies. J Cancer Res Clin Oncol 124(3–4):207–214
Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O (2012) Second malignancies after multiple myeloma: from 1960s to 2010s. Blood 119(12):2731–2737
Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91:4–15
Mendenhall NP, Noyes WD, Million RR (1989) Total body irradiation for stage II-IV non-Hodgkin’s lymphoma: ten-year follow-up. J Clin Oncol 7:67–74
Dobbs HJ, Barrett A, Rostom AY et al (1981) Total body irradiation in advanced non-Hodgkin’s lymphoma. Br J Radiol 54:878–881
Lybeert ML, Meerwaldt JH, Deneve W (1987) Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 13:1167–1172
Fourquet A, Teillaud JL, Lando D et al (1993) Effects of low dose total body irradiation and recombinant human interlukin-2 in mice. Radiother Oncol 26:219–225
Yonkosky DM, Feldman MI, Cathcart ES, Kim S (1978) Improvement of in-vitro mitogen proliferative responses in non-Hodgkin’s lymphoma patients exposed to fractionated total body irradiation. Cancer 42:1204–1210
Safwat A (2000) The role of low-dose total body irradiation in treatment of NHL: a new look at an old method. Radiother Oncol 56:1–8
Pollycove M (2007) Radiobiological basis of low-dose irradiation in prevention and therapy of cancer. Dose-Response 5(1):26–38
Nowosielska EM, Cheda A, Wrembel-Wargocka J, Janiak MK (2010) Immunological mechanism of the low-dose radiation-induced suppression of cancer metastases in a mouse model. Dose Response 8(2):209–226
Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M (2003) Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma. J Exp Ther Oncol 3:161–168
Hosoi Y, Sakamoto K (1993) Suppressive effect of low dose total body irradiation on lung metastasis: dose dependency and effective period. Radiother Oncol 26:177–179
Hosoi Y (2006) Antitumor effects by low dose total body irradiation. [Article in Japanese with English abstract] Yakugaku Zasshi 126(10):841–848
Safwat A, Schmidt H, Bastholt L et al (2005) A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma. Radiother Oncol 77:143–147
Sakamoto K, Myogin M, Hosoi Y (1997) Fundamental and clinical studies on cancer control with total or upper half body irradiation. J Jpn Soc Ther Radiol Oncol 16:161–175
Song KH, Kim MH, Kang SM et al (2015) Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation. Int J Radiat Biol 91(10):795–803
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
This article does not contain any studies with human participants performed by any of the authors.
Informed consent
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
Rights and permissions
About this article
Cite this article
Block, A.M., Silva, S.R. & Welsh, J.S. Low-dose total body irradiation: an overlooked cancer immunotherapy technique. J Radiat Oncol 6, 109–115 (2017). https://doi.org/10.1007/s13566-017-0303-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-017-0303-x